 DECEMBER 2008 DINNER MEETING with San Jose Chapter  |
||||||||||||||||||||||||||
|
Integrated
Design: The Key to Success for Biotech Facilities Thursday, December 4, 2008 (5:30 pm to 9:00 pm) Genentech Building 33, South San Francisco (map & directions) Registration deadline: 5pm, Monday, November 24 |
||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||
|
Agenda: |
|
|||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||
|
Speaker(s): |
Doug DeVeny, Director, Design Engineering, Genentech,
South San Francisco
Doug DeVeny has been with Genentech since September 2005. As Director of Design Engineering, he provides management and technical leadership in the architectural, electrical, mechanical and civil/structural disciplines for the design, construction, start-up, and validation of Genentech’s capital facility projects worldwide. He is also responsible for developing and implementing design standards and guidelines for Genentech’s administrative, research and development, and manufacturing facilities, including cost effective methods for engineering solutions. In addition, Doug leads the Environmental Sustainability Team, providing corporate guidance for Genentech projects involving energy and water use, transportation, as well as raw materials and waste management. Previously, as Manager of Architecture at Jacobs Engineering in Cincinnati, Ohio, Doug led architects and designers in the conceptual design through construction support of multiple pharmaceutical-related projects. Prior to his management role at Jacobs Engineering, he was a project architect at a variety of architectural firms specializing in the design of commercial facilities. Doug has over 24 years of practice, management and leadership of architectural and engineering design for pharmaceutical manufacturing, laboratory, chemical process, medical, office, commercial, educational and residential projects. He is a licensed architect in several states, including California, with a B.Arch degree from the University of Cincinnati. He has extensive experience providing programming, master planning, design and construction support for a variety of pharmaceutical clients, including Genentech, Wyeth, Eli Lilly, Abbott, Genzyme, BioMarin and Bayer. |
|||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||
|
Presentation |
In complex projects like the type you find in the
Biotech sector, an integrated design approach is essential for
success. Sub-optimal performance in any single area puts the success
of the entire facility at risk. The success of anyone working on a
biotech facility project relies on the individual achievements of
every member on the design and construction team.
Doug will present on several aspects that are vital for success in Biotech Facilities including: Regulatory versus Building Code compliance; Operational versus Process flow; Energy efficiency versus Air Change requirements; Quality versus Schedule speed. Resolving the seemingly endless list of inherently contradictory demands of biotech facilities requires extreme focus on the interdependence of multiple, complex technical systems and architectural interfaces |
|||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||
|
Cost: |
|
|||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||
Comments about this site can be sent to Robert Marcial at
<rmarcial@pacbell.net>.
© Copyright ASHRAE Golden Gate Chapter.